Relmada Therapeutics, Inc. RLMD Professional Service Fees Payable
Professional Service Fees Payable at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s professional service fees payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s professional service fees payable?
- Relmada Therapeutics, Inc. (RLMD) reported professional service fees payable of $312.9K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s professional service fees payable changed year-over-year?
- Relmada Therapeutics, Inc.'s professional service fees payable decreased by 0.1% year-over-year, from $313.2K to $312.9K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s professional service fees payable?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s professional service fees payable has grown at a 7.8% compound annual growth rate (CAGR), from $150.9K to $220K.
- What does professional service fees payable mean?
- Outstanding amounts owed to external consultants, legal counsel, auditors, or other professional service providers for work completed. This liability represents the company's short-term obligations for essential administrative and operational support. Consistent monitoring ensures the company is maintaining its vendor relationships and managing its short-term payables effectively.